Trials / Completed
CompletedNCT02003898
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 372 (actual)
- Sponsor
- Medtronic MiniMed, Inc. · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the Threshold Suspend (TS) feature of the Medtronic MiniMed® 530G insulin pump in patients 16 and older with insulin requiring diabetes.
Detailed description
Multi-center trial is initiated to observe the Threshold Suspend (TS) feature with a sensor-augmented insulin pump (Medtronic MiniMed® 530G insulin pump) in patients 16 and older with insulin requiring diabetes over a period of one year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Medtronic MiniMed 530G Insulin Pump |
Timeline
- Start date
- 2013-11-26
- Primary completion
- 2018-02-20
- Completion
- 2018-02-20
- First posted
- 2013-12-06
- Last updated
- 2019-03-05
- Results posted
- 2019-03-05
Locations
43 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02003898. Inclusion in this directory is not an endorsement.